Auditory verbal hallucinations (AVHs) are known as a core symptom of schizophrenia, but also occur in a number of other conditions, not least in neurodegenerative disorders such as dementia. In the last decades, Transcranial Magnetic Stimulation (TMS) emerged as a valuable therapeutic approach towards several neurological and psychiatric diseases, including AVHs. Herein we report a case of a seventy-six-years-old woman with vascular-degenerative brain disease, complaining of threatening AVHs. The patient was treated with a high-frequency temporoparietal (T3P3) rTMS protocol for fifteen days. A considerable reduction of AVHs in frequency and content (no more threatening) was observed. Although further research is needed, this seems an encouraging result.
1. Introduction
Transcranial Magnetic Stimulation (TMS) is a noninvasive technique of neuromodulation and neurostimulation based on the principle of electromagnetic induction of an electric field in the brain. It was originally developed for the of study brain function [1]. Since Barker and colleagues first demonstrated TMS, it has been widely used earlier to investigate motor conduction and control, later in the study of cognitive functions and brain plasticity. TMS is widely studied in the diagnosis and treatment of neurological and psychiatric diseases, too.
A hallucination is often referred to as “a sensory experience, which occurs in the absence of corresponding external stimulation of the relevant sensory organ, has a sufficient sense of reality to resemble a veridical perception, over which the subject does not feel s/he has direct and voluntary control and which occurs in the awake state” [2]. Auditory verbal hallucinations (AVHs) are defined as perceptions of speech without actual auditory stimulation and represent one of the most common hallucinatory experience, which are a characteristic symptom of schizophrenia [3] but also occur in a wealth of conditions, both neurological/neurodegenerative (e.g., epilepsy, Alzheimer’s disease, Parkinson’s disease, dementia, and hearing impairment) or psychiatric (e.g., dissociative disorders, mood disorders, and borderline personality disorder).
2. TMS and Auditory Hallucinations
Hoffman and colleagues [4] published the first report demonstrating a reduction in auditory verbal hallucinations (AVHs) after a low-frequency (1 Hz) rTMS treatment to the posterior superior temporal gyrus (STG). This brain area and, overall, the temporoparietal cortex (TPC) are involved in speech perception [5, 6] and are active during auditory hallucinations [7–9]. After the publication by Hoffman and colleagues, a number of studies replicated the positive findings using this rTMS protocol (for a complete review see Table 1), and, additionally, several meta-analyses supported the usefulness of rTMS in the treatment of hallucinations [10–12]. Most studies examined AVHs in schizophrenia, while there’s a lack of studies about TMS to treat hallucinations in dementia, even though a number of studies reported the presence of psychotic symptoms (mostly delusions and hallucinations) in Alzheimer’s and Parkinson’s diseases (for a more detailed review see [13, 14]).
Previous rTMS for AVHs studies.
Study
N active
N sham
Stimulated Area
Frequency
% MT
Session
Hoffman et al. [44]
12
12
T3P3
1 Hz
80
4
McIntosh et al. [45]
16
16
T3P3
1 Hz
80
4
Schönfeldt-Lecuona et al. [46]
11
10
STG
1 Hz
90
5
Chibbaro et al. [47]
8
8
T3P3
1 Hz
90
4
Fitzgerald et al. [48]
17
15
T3P3
1 Hz
90
10
Hoffman et al. [49]
27
23
T3P3
1 Hz
90
10
Lee et al. [50]
13
14
T3P3
1 Hz
100
10
Lee et al. [50]
12
14
T4P4
1 Hz
100
10
Poulet et al. [51]
10
10
T3P3
1 Hz
90
5
Brunelin et al. [52]
14
10
T3P3
1 Hz
90
10
Jandl et al. [53]
16
16
T3P3 T4P4
1 Hz
100
5
Jandl et al. [53]
16
16
T4P4
1 Hz
100
5
Rosa et al. [54]
6
5
T3P3
1 Hz
90
10
Saba et al. [55]
8
8
T3P3
1 Hz
80
10
Vercammen et al. [56]
16
16
T3P3
1 Hz
90
12
Vercammen et al. [56]
14
16
T3P3 T4P4
1 Hz
90
12
Loo et al. [57]
18
18
T3P3
1 Hz
110
3
Loo et al. [57]
18
18
T4P4
1 Hz
110
3
Slotema et al. [58]
22
20
T3P3
1 Hz
90
15
Slotema et al. [59]
20
20
fMRI
1 Hz
90
15
MT: motor threshold; T3P3: left temporoparietal cortex; T4P4: right temporoparietal cortex; STG: superior temporal gyrus; fMRI: functional magnetic resonance imaging.
3. RDOCs and Circuitries Involved
Though the exact pathophysiological mechanisms of AVHs remain actually unclear, neuroimaging studies have shown abnormalities in a distributed network of brain regions, providing valuable information about brain activity either during hallucinations or at rest. Studies on AVHs mainly employ neurophysiological methods (i.e., EEG), functional magnetic resonance imaging (fMRI), and, recently, transcranial magnetic stimulation (TMS). Most EEG studies showed changes in activity in the left superior temporal gyrus [15–18], not surprisingly since the involvement of this area in auditory processing. fMRI studies contributed much to understanding brain activity in AVHs: Allen and colleagues [19] proposed a neuroanatomical model of hallucinations including brain areas involved in linguistic processing, attention, memory, and emotion. In particular regarding AVHs, they hypothesized an altered connectivity between the superior temporal, inferior frontal gyrus and anterior cingulate cortex that might cause dysfunctional activation in language processing areas. Grounding upon the contribution of Hoffman et al. [20], the authors also hypothesized an increased activation or hypercoupling of speech production centers in the inferior frontal cortex and speech perception areas in left temporoparietal cortex. These areas seem to be specifically involved in the pathophysiology of AVHs, yet the model includes other brain regions such as Broca’s area, the dorsolateral prefrontal cortex (DLPFC), orbitofrontal cortex (OFC), the supplementary motor area (SMA), the dorsal and ventral anterior cingulate (DaC; VaC), the cerebellum, and a number of subcortical regions (Figure 1).
A neuroanatomical model of the hallucinating brain [19].
Recent contributions are divided into “state” studies (which investigated brain areas involved during AVH experience) and “trait” studies (which investigate the tendency to hallucinate) [21]. State studies highlighted the role of areas related to inner speech production such as the bilateral inferior frontal gyrus (IFG) and the bilateral postcentral gyrus, plus the left inferior parietal lobe (IPL) that could play a role in the misattribution of the speech as not being self-generated. On the other hand, trait studies focused on areas associated with speech perception such as the left superior temporal gyrus (STG) and left middle temporal gyrus (MTG) and anterior cingulate cortex (ACC) that could similar to left IPL play a role in the distorted self-monitoring of speech [22]. An involvement is also shown for putamen and Wernicke’s areas and its right homologue [23].
In conclusion, studies suggest that the core mechanisms of AVHs involve a complex functional loop including several brain areas interconnected, rather than a single pathway [23].
4. Auditory Verbal Hallucinations (AVH) in Other Disorders
Though the high prevalence in schizophrenia (40%–80%; [24]), AVHs are not specific for the disorder and, likewise, occur in the 10%–15% of nonclinical subjects [25, 26]. In healthy subjects, the presence of AVHs is frequently associated with subclinical levels of other schizotypal phenomena, plus an increased family loading for psychosis and axis I disorders and a higher prevalence of childhood trauma, but these subjects do not meet the criteria for schizotypal, schizoid, or paranoid disorders [27]. Furthermore, a crucial difference between the emotional content of AVHs in healthy individuals and patients with schizophrenia has been observed [28, 29]: while in schizophrenia AVHs are characterized by a negative emotional content leading to perceived distress and to a lower global functioning, voices of the healthy subjects mainly have a positive emotional content and are often not disturbing. This difference in the emotional content could distinguish between benign hallucinations and psychopathology.
In regard to clinical conditions, AVHs are frequently found in neurological or neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, dementia, hearing impairment and epilepsy [13, 30, 31], substance abuse [32], and in psychiatric conditions such as dissociative disorders, mood disorders, and borderline personality disorder [14, 33, 34]. In particular focusing on dementia, the presence of behavioral symptoms (mostly delusions and hallucinations) is significant, in particular in Alzheimer’s disease and vascular dementia [35]: specifically, the prevalence of AVHs ranges between 1% and 29% [13]. Hallucinations seem to slightly increase correlating with the severity of dementia on the Clinical Dementia Rating [35], with greater percentage (21%) in moderate dementia. Findings also showed that psychotic symptoms in dementia frequently lead to caregiver distress and, consequently, to institutionalization and greater cognitive deterioration [13, 14].
5. Case Presentation
A seventy-six-years-old woman presented with her daughter to the Institute, complaining of hearing disturbing voices (AVHs according to Neuropsychiatric Inventory Clinician (NPI-C; [36]) started on August 2012. She reported she firstly suffered from hypnagogic hallucinations represented by religious choirs which later turned into hearing her dead newborn son’s voice. These AVHs initially had a positive content, while afterwards she began to hear threatening voices associated with sleep disturbances. On presentation, she also reported fear of the dark and being left alone at home. A partial awareness of the hallucinating origin of the voices, typical in hallucinosis, distinguished her clinical picture from AVHs in psychosis. Her insight could be assessed through the Schedule for the Assessment of Insight (SAI; [37]): the woman showed quite high insight with regard to the recognition of her abnormal mental events and actively searched for treatment, accepting therapy with good adherence.
Magnetic resonance images showed bilaterally altered areas characterizing the periventricular and subcortical supratentorial white matter, in conjunction with vascular-degenerative subcortical encephalopathy features. The woman’s cognitive clinical picture was a Mild Cognitive Impairment, though the long-term duration and the clinical evidence of progression set the diagnosis of dementia.
The pharmacological treatment essentially consisted of risperidone, gradually decreased. However, AVHs has been shown to be particularly difficult-to-treat and resistant to pharmacotherapy, suggesting that the improvement reached was not attributable to pharmacological treatment.
On presentation, her cognitive function was assessed through the Mini Mental State Examination (MMSE; [38]) reaching a score of 25.24; the Symptoms Check-List 90-R (SCL 90-R; [39]) was also administered, showing high values on “obsessivity compulsivity” (40%), “depression” (37%), and “psychoticism” (50%) areas. The intensity and features of the auditory verbal hallucinations were assessed during a psychiatric interview, with the aid of the Neuropsychiatric Inventory Clinician (NPI-C; [36]). This instrument represents a comprehensive assessment tool for neuropsychiatric symptoms and psychopathology in Alzheimer’s disease and other neurodegenerative disorders. The main results showed neither delusions nor agitation, irritability, aggression, disinhibition or aberrant motor and verbal disturbances. Conversely, as previously mentioned, the patient complained about daily threatening voices which caused her sleep disturbances and, consequently, significant distress.
The woman was submitted to a 10 Hz rTMS treatment over T3P3 (temporoparietal cortex) at 80% motor threshold. The protocol of administration consisted in a 15-day daily treatment, with a stimulation sequence of 13 trains of 200 stimuli each (50 seconds intertrain interval), for an amount of 2600 stimuli. After treatment, the patient reported a marked reduction in AVHs: their frequency drastically decreased, their content loss threatening features, and, consequently, the associated distress considerably lowered. Also, no side effects were reported during all treatment and in the aftermath.
6. Discussion
Previous studies regarding the use of TMS in the treatment of AVHs mostly employed the low-frequency rTMS protocol firstly proposed by Hoffman and colleagues [4]. Yet, to date, most literature concerning the employ of TMS in AVHs focused for the most part on schizophrenic patients, which have considerably different traits compared to elderly people with neurodegenerative disorders. In addition, the absence of delusional features in hallucinations set the patient’s clinical picture markedly distant from psychosis: AVHs were not embedded in a delusional frame and not related to any particular delusional belief. Moreover, a partial awareness was preserved, almost giving the woman’s AVHs the features of hallucinosis. This, in addition to neurodegenerative phenomena highlighted by MRI, explains our choice for a high frequency rTMS protocol. Given the evidence of links interruptions between strategic temporal and frontal brain regions [40], we hypothesized different features of AVHs between schizophrenia and dementia. In particular, we supposed the primary role of a disconnective syndrome rather than cortical hyperactivity [41–43] in dementia: this explains our choice of the rTMS protocol mentioned above.
On the other hand, as far as we know, the literature concerning AVHs in elderly people did not contemplate the employ of TMS as a therapeutic tool. Hence, this contribution sets in a promising field of extending the therapeutic purposes of TMS: this latter proves as potentially useful also in some difficult-to-treat neurodegenerative disorders symptoms, such as behavioral symptoms. Currently, no specific therapeutic guidelines are available for behavioral symptoms, in particular for pharmacoresistant AVHs: TMS could represent a valuable treatment because of its effect on multiple symptoms. In particular, AVHs improvement is associated with mood and cognitive improvement: we actually cannot establish a causative connection affirming which is the primary target of rTMS treatment, but, as far as we know, we can observe its effects both on AVHs, mood, and cognition. Though further research is needed, this represents a first, encouraging result: next step could be an analysis of changes in functional and metabolic brain activity after rTMS treatment.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
BarkerA. T.JalinousR.FreestonI. L.Non-invasive magnetic stimulation of human motor cortex198518437110611072-s2.0-0021802893DavidA. S.The cognitive neuropsychiatry of auditory verbal hallucinations: an overview200491-21071232-s2.0-124228593710.1080/13546800344000183SartoriusN.JablenskyA.KortenA.Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders19861649099282-s2.0-0023024474HoffmanR. E.BoutrosN. N.BermanR. M.RoesslerE.BelgerA.KrystalJ. H.CharneyD. S.Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated ‘voices’19994611301322-s2.0-003305545310.1016/S0006-3223(98)00358-8FiezJ. A.RaichleM. E.BalotaD. A.TallalP.PetersenS. E.PET activation of posterior temporal regions during auditory word presentation and verb generation199561110BensonR. R.WhalenD. H.RichardsonM.SwainsonB.ClarkV. P.LaiS.LibermanA. M.Parametrically dissociating speech and nonspeech perception in the brain using fMRI20017833643962-s2.0-003482718910.1006/brln.2001.2484SilbersweigD. A.SternE.FrithC.CahillC.HolmesA.GrootoonkS.SeawardJ.MckennaP.ChuaS. E.SchnorrL.JonesT.FrackowiakR. S. J.A functional neuroanatomy of hallucinations in schizophrenia199537865531761792-s2.0-0028847356LennoxB. R.ParkS. B. G.MedleyI.MorrisP. G.JonesP. B.The functional anatomy of auditory hallucinations in schizophrenia2000100113202-s2.0-003469434810.1016/S0925-4927(00)00068-8ShergillS. S.BrammerM. J.WilliamsS. C. R.MurrayR. M.McGuireP. K.Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging20005711103310382-s2.0-0033764501AlemanA.SommerI. E.KahnR. S.Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis20076834164212-s2.0-33947722305FreitasC.FregniF.Pascual-LeoneA.Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia20091081–311242-s2.0-6024909746510.1016/j.schres.2008.11.027SlotemaC. W.BlomJ. D.HoekH. W.SommerI. E. C.Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders20107178738842-s2.0-7795529752410.4088/JCP.08m04872greBassionyM. M.LyketsosC. G.Delusions and hallucinations in Alzheimer's disease: review of the brain decade20034453884012-s2.0-004183620710.1176/appi.psy.44.5.388LarøiF.SommerI. E.BlomJ. D.FernyhoughC.HugdahlK.JohnsL. C.The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions201238472473310.1093/schbul/sbs061IshiiR.ShinosakiK.IkejiriY.UkaiS.YamashitaK.IwaseM.Mizuno-MatsumotoY.InouyeT.YoshimineT.HirabukiN.RobinsonS. E.TakedaM.Theta rhythm increases in left superior temporal cortex during auditory hallucinations in schizophrenia: a case report20001114328332872-s2.0-0034727468ReulbachU.BleichS.MaihöfnerC.KornhuberJ.SperlingW.Specific and unspecific auditory hallucinations in patients with schizophrenia: a magnetoencephalographic study200755289952-s2.0-3444757090010.1159/000103907RopohlA.SperlingW.ElstnerS.TomandlB.ReulbachU.KaltenhäuserM.KornhuberJ.MaihöfnerC.Cortical activity associated with auditory hallucinations20041535235262-s2.0-154235758610.1097/00001756-200403010-00028SritharanA.LineP.SergejewA.SilbersteinR.EganG.CopolovD.EEG coherence measures during auditory hallucinations in schizophrenia20051362-31892002-s2.0-2884448419410.1016/j.psychres.2005.05.010AllenP.LarøiF.McGuireP. K.AlemanA.The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations20083211751912-s2.0-3634897053810.1016/j.neubiorev.2007.07.012HoffmanR. E.HampsonM.WuK.AndersonA. W.GoreJ. C.BuchananR. J.ConstableR. T.HawkinsK. A.SahayN.KrystalJ. H.Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation20071711273327432-s2.0-3454825820410.1093/cercor/bhl183van LutterveldR.2012Utrecht, The NetherlandsRudolph Magnus Institute of Neuroscience, University Medical CenterKuhnS.GallinatJ.Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia2011384779786HoffmanR. E.FernandezT.PittmanB.HampsonM.Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia20116954074142-s2.0-7995168246010.1016/j.biopsych.2010.09.050AlemanA.LarøiF.2008Washington, DC, USAAmerican Psychological AssociationTienA. Y.Distributions of hallucinations in the population19912662872922-s2.0-0026353965BeavanV.ReadJ.CartwrightC.The prevalence of voice-hearers in the general population: a literature review20112032812922-s2.0-7995614184210.3109/09638237.2011.562262SommerI. E.DaalmanK.RietkerkT.DiederenK. M.BakkerS.WijkstraJ.BoksM. P. M.Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects20103636336412-s2.0-7795322033010.1093/schbul/sbn130HonigA.RommeM. A. J.EnsinkB. J.EscherS. D. M. A. C.PenningsM. H. A.DevriesM. W.Auditory hallucinations: a comparison between patients and nonpatients1998186106466512-s2.0-003172217610.1097/00005053-199810000-00009ChoongC.HunterM. D.WoodruffP. W. R.Auditory hallucinations in those populations that do not suffer from schizophrenia2007932062122-s2.0-3425017085510.1007/s11920-007-0020-zMatsuiH.NishinakaK.MiyoshiT.HaraN.OdaM.KuboriT.UdakaF.Thalamic hyperperfusion in verbal hallucination of Parkinsonian patients20074621176517692-s2.0-3624902323910.2169/internalmedicine.46.0191SommerI. E.KoopsS.BlomJ. D.Comparison of auditory hallucinations across different disorders and syndromes201221112PeräläJ.KuoppasalmiK.PirkolaS.HärkänenT.SaarniS.Tuulio-HenrikssonA.ViertiöS.LatvalaA.KoskinenS.LönnqvistJ.SuvisaariJ.Alcohol-induced psychotic disorder and delirium in the general population201019732002062-s2.0-7795692074210.1192/bjp.bp.109.070797BaethgeC.BaldessariniR. J.FreudenthalK.StreeruwitzA.BauerM.BschorT.Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia2005721361452-s2.0-1594439607710.1111/j.1399-5618.2004.00175.xKingdonD. G.AshcroftK.BhandariB.GleesonS.WarikooN.SymonsM.TaylorL.LucasE.MahendraR.GhoshS.MasonA.BadrakalimuthuR.HepworthC.ReadJ.MehtaR.Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma201019863994032-s2.0-7795333116210.1097/NMD.0b013e3181e08c27LyketsosC. G.SteinbergM.TschanzJ. T.NortonM. C.SteffensD. C.BreitnerJ. C. S.Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging200015757087142-s2.0-003401637210.1176/appi.ajp.157.5.708CummingsJ. L.MegaM.GrayK.Rosenberg-ThompsonS.CarusiD. A.GornbeinJ.The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia19944412230823142-s2.0-0027985334DavidA. S.Insight and psychosis19901567988082-s2.0-0025349021FolsteinM. F.FolsteinS. E.McHughP. R.‘Mini mental state’. A practical method for grading the cognitive state of patients for the clinician19751231891982-s2.0-001682381010.1016/0022-3956(75)90026-6DerogatisL. R.1977Chicago, Ill, USASchool of Medicine, Johns Hopkins UniversityLannaM. E.AlvesC. E.SudoF. K.AlvesG.ValenteL.MoreiraD. M.CavalcantiJ. L.EngelhardtE.Cognitive disconnective syndrome by single strategic stroke in vascular dementia20123221-217618310.1016/j.jns.2012.08.004SilbertL. C.NelsonC.HolmanS.EatonR.OkenB. S.LouJ. S.KayeJ. A.Cortical excitability and age-related volumetric MRI changes20061175102910362-s2.0-3364648307310.1016/j.clinph.2006.02.003AlbericiA.BonatoC.CalabriaM.AgostiC.ZanettiO.MiniussiC.PadovaniA.RossiniP. M.BorroniB.The contribution of TMS to frontotemporal dementia variants200811842752802-s2.0-5134914256610.1111/j.1600-0404.2008.01017.xPennisiG.FerriR.LanzaG.CantoneM.PennisiM.PuglisiV.MalaguarneraG.BellaR.Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability201111845875982-s2.0-7995622677410.1007/s00702-010-0554-9HoffmanR. E.BoutrosN. N.HuS.BermanR. M.KrystalJ. H.CharneyD. S.Transcranial magnetic stimulation and auditory hallucinations in schizophrenia20003559209107310752-s2.0-0034712464McIntoshA. M.SempleD.TaskerK.HarrisonL. K.OwensD. G. C.JohnstoneE. C.EbmeierK. P.Transcranial magnetic stimulation for auditory hallucinations in schizophrenia20041271-29172-s2.0-314275858110.1016/j.psychres.2004.03.005Schönfeldt-LecuonaC.GrönG.WalterH.BüchlerN.WunderlichA.SpitzerM.HerwigU.Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia20041510166916732-s2.0-324278319410.1097/01.wnr.0000126504.89983.ecChibbaroG.DanieleM.AlagonaG.di PasqualeC.CannavòM.RapisardaV.BellaR.PennisiG.Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations20053831-254572-s2.0-2034439408910.1016/j.neulet.2005.03.052FitzgeraldP. B.BenitezJ.DaskalakisJ. Z.BrownT. L.MarstonN. A. U.de CastellaA.KulkarniJ.A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations20052543583622-s2.0-2304443923910.1097/01.jcp.0000168487.22140.7fHoffmanR. E.GueorguievaR.HawkinsK. A.VarankoM.BoutrosN. N.WuY.-T.CarrollK.KrystalJ. H.Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample2005582971042-s2.0-2244444447310.1016/j.biopsych.2005.03.041LeeS.-H.KimW.ChungY.-C.JungK.-H.BahkW.-M.JunT.-Y.KimK.-S.GeorgeM. S.ChaeJ.-H.A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations200537631771812-s2.0-1384426633310.1016/j.neulet.2004.11.048PouletE.BrunelinJ.BediouB.BationR.ForgeardL.DaleryJ.D'AmatoT.SaoudM.Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia20055721881912-s2.0-1184426340210.1016/j.biopsych.2004.10.007BrunelinJ.PouletE.BediouB.KallelL.DaleryJ.D'amatoT.SaoudM.Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia200681141452-s2.0-2914451664710.1016/j.schres.2005.10.009JandlM.SteyerJ.WeberM.LindenD. E. J.RothmeierJ.MaurerK.KaschkaW. P.Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial200653263692-s2.0-3364596526110.1159/000091721RosaM. O.GattazW. F.RosaM. A.RumiD. O.TavaresH.MyczkowskiM.SartorelliM. C.RigonattiS. P.ElkisH.CabralS. B.TeixeiraM. J.MarcolinM. A.Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine20076810152815322-s2.0-35948993005SabaG.VerdonC. M.KalalouK.RocamoraJ. F.DumortierG.BenadhiraR.StamatiadisL.VicautE.LipskiH.JanuelD.Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study20064021471522-s2.0-3164443563910.1016/j.jpsychires.2005.02.008VercammenA.KnegteringH.BruggemanR.WestenbroekH. M.JennerJ. A.SlooffC. J.WunderinkL.AlemanA.Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial20091141–31721792-s2.0-6984908647210.1016/j.schres.2009.07.013LooC. K.SainsburyK.MitchellP.Hadzi-PavlovicD.SachdevP. S.A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations20104045415462-s2.0-7795242474410.1017/S0033291709990900SlotemaC. W.BlomJ. D.de WeijerA. D.DiederenK. M.GoekoopR.LooijestijnJ.DaalmanK.RijkaartA.-M.KahnR. S.HoekH. W.SommerI. E. C.Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial20116954504562-s2.0-7995168354210.1016/j.biopsych.2010.09.051SlotemaC. W.BlomJ. D.HoekH. W.SommerI. E. C.Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders20107178738842-s2.0-7795529752410.4088/JCP.08m04872gre